Skip to main content
ENCell Co., Ltd. logo

ENCell Co., Ltd. — Investor Relations & Filings

Ticker · 456070 ISIN · KR7456070002 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2025-08-18 Regulatory Filings
Country KR South Korea
Listing KO 456070

About ENCell Co., Ltd.

http://www.encellinc.com/en/

ENCell Co., Ltd. is a biopharmaceutical company specializing in advanced cell and gene therapies (CGT). The company's primary focus is providing Contract Development and Manufacturing Organization (CDMO) services, supported by globally recognized GMP facilities. Its offerings include process development, manufacturing, and contract quality testing (CQT) for a diverse portfolio of advanced therapies, including MSC, CAR-T, CAR-NK, and iPSC-derived cell therapies. ENCell leverages proprietary technologies such as the ROCKET Platform for multi-product GMP production and a next-generation stem cell platform designed to enhance yield and efficacy. In addition to its CDMO business, the company develops its own therapeutic pipeline. This internal research and development focuses on next-generation stem cell treatments, cancer immunotherapy, and AAV-based gene therapies, with a program for Duchenne Muscular Dystrophy in development.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획변경승인신청) (샤르코마리투스(CharcotMarieTooth disease, CMT) 1A형 환자를 대상으로 EN001의 유효성 및 안전성을 평가하기 위해 1b/2a상 임상시험계획 변경승인을 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a South Korean company (EnCell) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically an application for a change in clinical trial approval (임상시험계획 변경승인신청) submitted to the Ministry of Food and Drug Safety (MFDS). As this is a specific regulatory disclosure regarding clinical trial status and does not fit into categories like earnings releases, annual reports, or board changes, it is classified as a general regulatory filing.
2025-08-18 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '이엔셀(주)' covering the period from 2025-01-01 to 2025-06-30. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by ENCELL. It details the contract value, counterparty (Public Procurement Service), contract duration, and payment terms. In the context of Korean regulatory filings (DART), this is a standard disclosure of a major contract, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or Dividend announcements.
2025-07-03 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by the company ENCELL. It details the contract value, counterparty nature, duration, and payment terms. Since this is a specific regulatory disclosure regarding a material business contract that does not fit into financial reporting, governance, or shareholder meeting categories, it is classified as a general regulatory filing.
2025-05-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders and special related parties, including specific disclosure of shareholding percentages and reasons for changes (e.g., resignation of an executive). This corresponds to the 'Major Shareholding Notification' category.
2025-05-20 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '이엔셀(주)' covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial statements, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.